GLP-1 patient volume exhibited consistent and substantial growth throughout the observation period, with an initial 37.9% increase in 2019, ultimately reaching a 744.6% increase by 2023 relative to the 2018 baseline (Figure 1)
103105, Lenton, Kevin J et al
Granja MG, Alves LP, Leardini-Tristo M, Saul ME, Bortoni LC, de Moraes FM, et al
Endogenous GLP-1 tends to peak in the late afternoon and evening, roughly between 5:30 PM and 6 PM, with lowest levels occurring at night
Liraglutide is a well-established GLP-1 medication that supports gradual and sustained weight loss when combined with healthy diet and exercise
For individuals with insurance, the out-of-pocket cost can vary based on your plans coverage for diabetes and weight loss treatments